Spitzer, T R <br/><br/>
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies.  [electronic resource] 

 -  Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation  2000 
 - 309-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1083-8791 
<br/><br/><label>Standard No.: </label>10.1016/s1083-8791(00)70056-5  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Antilymphocyte Serum<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Bone Marrow Transplantation--adverse effects<br/>Cell Survival<br/>Combined Modality Therapy<br/>Cyclophosphamide--adverse effects<br/>Cyclosporine<br/>Disease-Free Survival<br/>Drug Resistance, Neoplasm<br/>Female<br/>Follow-Up Studies<br/>Genotype<br/>Graft Enhancement, Immunologic<br/>Graft Survival<br/>Graft vs Host Disease--etiology<br/>Graft vs Leukemia Effect<br/>HLA Antigens--analysis<br/>Heart Diseases--chemically induced<br/>Hematologic Neoplasms--drug therapy<br/>Histocompatibility<br/>Humans<br/>Leukocyte Transfusion--adverse effects<br/>Male<br/>Mice<br/>Middle Aged<br/>Models, Animal<br/>Phenotype<br/>Remission Induction<br/>Reproducibility of Results<br/>Salvage Therapy<br/>Survival Analysis<br/>T-Lymphocytes--immunology<br/>Thymus Gland--radiation effects<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous--adverse effects<br/>Treatment Outcome